Logo
DCA

Becton, Dickinson and Company

sp500
BDXHealthcareMedical Instruments & Supplies
144,43 $US
-0.62%
Ultimo Prezzo
144,43 $US
2026-06-02
Variazione 24h
-0.62%
-0.90 USD
Volume
2,1 Mio
Azioni scambiate
Affidabilità Dati
Alta
13433 punti (53 anni)

Evoluzione del prezzo

Avvia una simulazione con questo asset

BDX

Parametri globali

Dati disponibili dal 21/02/1973 al 02/06/2026

Analisi Fondamentale

New
CAGR (5y)
4.99%
Revenue Growth
Net Margin
7.68%
Profitability
ROE
6.61%
Return on Equity
Debt / EBITDA
3.87
Solvency
PEG Ratio
1.15
Valuation vs Growth
Rev. Growth (TTM)
1.60%
Current Trend

Storico P/E (5 anni)

Historical PE
Average (40.0x)
Current: 24.4x
Focus tecnico
BDX
Volatilità 30g
26.04%
Distanza da MA50
-4.41%
Distanza da MA200
-19.60%
Distanza da ATH
-49.07%
Momentum 3M
-15.78%
Punteggio rischio
N/A

Volatilità moderata. Momentum neutro.

Su Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Investire in questo asset
Compra su Saxo Bank
🏦Broker regolamentato
🌍Accesso ai mercati globali
📈Strumenti Pro

Link pubblicitario. Capitale a rischio.

Analisi Tecnica e Rischio

Metriche Chiave

CAGR8.11%
Volatilità26.04%
Max Drawdown-49.80%

Momentum : BDX

Indicateur synthétique
PEURNEUTREAVIDITÉ
40
Fear

Analisi Rischio

VaR (95%)-2.39%
Salute DCA
86/100

Storia Recente (60 giorni)

DataChiusuraVolume
2026-06-02144,43 $US2.085.837
2026-06-01145,33 $US2.353.996
2026-05-29147,12 $US3.658.099
2026-05-28148,41 $US2.456.040
2026-05-27147,24 $US2.878.200
2026-05-26147,75 $US3.243.481
2026-05-22147,63 $US1.004.167
2026-05-21146,25 $US1.574.560
2026-05-20146,95 $US2.057.077
2026-05-19146,95 $US3.053.565
2026-05-18142,35 $US3.773.030
2026-05-15143,47 $US4.277.310
2026-05-14144,47 $US2.319.158
2026-05-13144,18 $US3.650.067
2026-05-12147,51 $US3.465.234
2026-05-11143,15 $US3.378.688
2026-05-08149,43 $US4.019.734
2026-05-07153,26 $US5.132.482
2026-05-06144,76 $US3.399.234
2026-05-05144,17 $US2.810.660
2026-05-04146,31 $US1.925.651
2026-05-01149,31 $US1.818.077
2026-04-30149,04 $US1.943.949
2026-04-29145,31 $US2.917.648
2026-04-28149,52 $US2.094.893
2026-04-27150,22 $US2.681.313
2026-04-24152,14 $US1.729.488
2026-04-23154,85 $US2.664.370
2026-04-22155,65 $US1.957.052
2026-04-21156,69 $US3.209.625
2026-04-20158,64 $US3.235.577
2026-04-17158,54 $US2.832.669
2026-04-16154,82 $US3.372.109
2026-04-15155,52 $US2.013.286
2026-04-14155,73 $US2.338.838
2026-04-13155,43 $US2.880.880
2026-04-10154,22 $US1.694.892
2026-04-09155,46 $US1.995.252
2026-04-08157,09 $US2.186.904
2026-04-07154,96 $US1.365.096
2026-04-06155,32 $US1.875.904
2026-04-02154,51 $US1.822.914
2026-04-01156,34 $US1.620.945
2026-03-31157,23 $US1.769.376
2026-03-30154,69 $US1.498.843
2026-03-27154,51 $US1.855.730
2026-03-26157,38 $US2.369.969
2026-03-25158,27 $US1.323.500
2026-03-24155,92 $US2.218.350
2026-03-23156,23 $US1.652.406
2026-03-20154,13 $US3.722.926
2026-03-19156,53 $US1.638.944
2026-03-18158,08 $US1.681.443
2026-03-17161,64 $US2.154.435
2026-03-16160,27 $US2.184.032
2026-03-13159,36 $US1.939.747
2026-03-12159,63 $US2.372.988
2026-03-11163,17 $US3.219.144
2026-03-10163,88 $US2.528.200
2026-03-09165,46 $US2.343.646

Dividendi Recenti

DataImporto
2026-03-10+1,05 $US
2025-12-08+1,05 $US
2025-09-08+1,04 $US
2025-06-09+1,04 $US
2025-03-10+1,04 $US
2024-12-09+1,04 $US
2024-09-09+0,95 $US
2024-06-10+0,95 $US
2024-03-07+0,95 $US
2023-12-07+0,95 $US
2023-09-07+0,91 $US
2023-06-08+0,91 $US
2023-03-09+0,91 $US
2022-12-08+0,91 $US
2022-09-08+0,87 $US
2022-06-08+0,87 $US
2022-03-09+0,85 $US
2021-12-09+0,85 $US
2021-09-08+0,81 $US
2021-06-08+0,81 $US

Asset Correlati